Graham Capital Management »

Zenas Biopharma shares owned by Graham Capital Management

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.6M 2.5M 1.04

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Gold Miners Etf (GDX)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Applied Digital Corp Note 2.750% 6/0 (Principal)
Amazon (AMZN)
Green Plains Note 5.250%11/0 (Principal)
Calumet Put Option (CLMT)
Sunrun Note 4.000% 3/0 (Principal)
Tilray Brands Note 5.200% 6/1 (Principal)
Purecycle Technologies Note 7.250% 8/1 (Principal)
Rivian Automotive Note 3.625%10/1 (Principal)
Groupon Note 4.875% 6/3 (Principal)
NVIDIA Corporation (NVDA)
The Realreal Debt 4.000% 2/1 (Principal)

View all positions for Graham Capital Management

Top funds holding Zenas Biopharma

Deerfield Management Company
Context Capital Management
Jpmorgan Chase & Co
Braidwell
Jane Street
Citadel Advisors
Leucadia National Corporation
Capstone Investment Advisors
Monashee Investment Management
D. E. Shaw & Co
Calamos Advisors
Graham Capital Management
Woodline Partners
Millennium Management
Aristeia Capital

View all funds holding Zenas Biopharma